Approval · Notice of Compliance 4522 · 1996
BIANDA: Notice of Compliance 4522
Issued February 19, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4522
- Date
- February 19, 1996
- Company
- Du Pont Merck Pharma Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BIANDA | 02211114 | — |
Medicinal ingredients
- LOSOXANTRONE 25 MG per VIAL